Adidas Ag v. Nike, Inc.

963 F.3d 1355
CourtCourt of Appeals for the Federal Circuit
DecidedJune 25, 2020
Docket19-1787
StatusPublished
Cited by12 cases

This text of 963 F.3d 1355 (Adidas Ag v. Nike, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Adidas Ag v. Nike, Inc., 963 F.3d 1355 (Fed. Cir. 2020).

Opinion

Case: 19-1787 Document: 64 Page: 1 Filed: 06/25/2020

United States Court of Appeals for the Federal Circuit ______________________

ADIDAS AG, Appellant

v.

NIKE, INC., Appellee ______________________

2019-1787, 2019-1788 ______________________

Appeals from the United States Patent and Trademark Office, Patent Trial and Appeal Board in Nos. IPR2016- 00921, IPR2016-00922. ______________________

Decided: June 25, 2020 ______________________

MITCHELL G. STOCKWELL, Kilpatrick Townsend & Stockton LLP, Atlanta, GA, for appellant. Also repre- sented by VAIBHAV P. KADABA, MICHAEL T. MORLOCK, TIFFANY L. WILLIAMS.

CHRISTOPHER J. RENK, Banner & Witcoff, Ltd., Chicago, IL, for appellee. Also represented by KEVIN DAM, MICHAEL JOSEPH HARRIS. ______________________

Before MOORE, TARANTO, and CHEN, Circuit Judges. Case: 19-1787 Document: 64 Page: 2 Filed: 06/25/2020

MOORE, Circuit Judge. Nike, Inc. owns U.S. Patent Nos. 7,814,598 and 8,266,749, which share a specification and are directed to methods of manufacturing an article of footwear with a tex- tile upper. See ’598 patent at 1:18–21. Adidas AG peti- tioned for inter partes review of claims 1–13 of the ’598 patent and claims 1–9, 11–19 and 21 of the ’749 patent. The Board held that Adidas had not demonstrated that the challenged claims are unpatentable as obvious. Adidas ap- peals. Because the Board did not err in its obviousness analysis and substantial evidence supports its underlying factual findings, we affirm. I. Standing “Although we have jurisdiction to review final decisions of the Board under 28 U.S.C. § 1295(a)(4)(A), an appellant must meet ‘the irreducible constitutional minimum of standing.’” Amerigen Pharm. Ltd. v. UCB Pharma GmBH, 913 F.3d 1076, 1082 (Fed. Cir. 2019) (quoting Lujan v. De- fenders of Wildlife, 504 U.S. 555, 560 (1992)). As the party seeking judicial review, Adidas must show that it “(1) suf- fered an injury in fact, (2) that is fairly traceable to the challenged conduct [], and (3) that is likely to be redressed by a favorable judicial decision.” Spokeo, Inc. v. Robins, 136 S. Ct. 1540, 1547 (2016). Nike contends that Adidas cannot establish an “injury in fact,” and therefore lacks standing to bring this appeal, because Nike “has not sued or threatened to sue Adidas for infringement of either the ’598 or the ’749 patent.” Appellant’s Br. 20. We do not agree. An appellant need not face “a specific threat of infringe- ment litigation by the patentee” to establish the requisite injury in an appeal from a final written decision in an inter partes review. E.I. DuPont de Nemours & Co. v. Synvina C.V., 904 F.3d 996, 1004 (Fed. Cir. 2018). Instead, “it is generally sufficient for the appellant to show that it has engaged in, is engaging in, or will likely engage in activity Case: 19-1787 Document: 64 Page: 3 Filed: 06/25/2020

ADIDAS AG v. NIKE, INC. 3

that would give rise to a possible infringement suit.” Grit Energy Sols., LLC v. Oren Techs., LLC, 957 F.3d 1309, 1319 (Fed. Cir. 2020). In DuPont, we held that the appellant had standing because it had concrete plans to make a poten- tially infringing product, including actually completing the necessary production plant, and thus there was a substan- tial risk of future infringement. DuPont, 904 F.3d at 1005. We determined that the patent owner’s refusal to grant ap- pellant a covenant not to sue further confirmed that appel- lant’s risk of injury was not “conjectural” or “hypothetical.” Id. As in DuPont, Adidas and Nike are direct competitors. J.A. 2584. In 2012, Nike accused Adidas, based on Adidas’ introduction of its “Primeknit” products, of infringing one of Nike’s “Flyknit” patents 1—specifically, a German pa- tent—and expressed its intent “to protect [Nike’s] rights globally in the future against further infringing acts” by Adidas. J.A. 2585–86; 2591–2613. Adidas markets shoes that contain Primeknit-based uppers in the United States. J.A. 2587. Although Nike has not yet accused Adidas of infringing the ’598 or ’749 patents, Nike has asserted the ’749 patent against a third-party product similar to Adidas’ footwear. J.A. 2587–90, 2678–93. In 2019, Nike told this court that “five months after [it] announced FLYKNIT, [A]didas announced a similar product of its own that it called ‘Primeknit.’” J.A. 2587 (emphasis added). Moreover, Nike has refused to grant Adidas a covenant not to sue, confirming that Adidas’ risk of infringement is concrete and substantial. See DuPont, 904 F.3d at 1005. We there- fore conclude that Adidas has Article III standing to bring this appeal.

1 Nike has a portfolio of “more than 300 issued utility patents,” including the ’749 patent, directed to its Flyknit technology. J.A. 2652. Case: 19-1787 Document: 64 Page: 4 Filed: 06/25/2020

II. Obviousness The challenged claims recite a method of “mechani- cally-manipulating a yarn with a circular knitting ma- chine . . . to form a cylindrical textile structure.” ’598 patent at 3:41–46. The claimed method involves removing a textile element from the textile structure and incorporat- ing it into an upper of the article of footwear. Id. at 3:41– 46. Claims 4 and 11 of the ’598 patent and claims 11 and 21 of the ’749 patent (collectively, the Unitary Construction Claims) require that the textile element is a single material element wherein portions of the textile element have dif- ferent textures and “are not joined together by seams or other connections.” Id. at 5:40–43, 6:41–50. The other challenged claims (collectively, the Base Claims) are not so limited. Claim 1 of the ’598 patent is illustrative of the Base Claims: 1. A method of manufacturing an article of foot- wear, the method comprising steps of: mechanically-manipulating a yarn with a circular knitting machine to form a cylindrical textile struc- ture; removing at least one textile element from the tex- tile structure; incorporating the textile element into an upper of the article of footwear. ’598 patent at Claim 1. Claim 4 of the ’598 patent is illus- trative of the Unitary Construction Claims: 4. The method recited in claim 1, wherein the step of mechanically manipulating includes forming the textile element to include a first area and a second area with a unitary construction, the first area be- ing formed of a first stitch configuration, and the second area being formed of a second stitch Case: 19-1787 Document: 64 Page: 5 Filed: 06/25/2020

ADIDAS AG v. NIKE, INC. 5

configuration that is different from the first stitch configuration to impart varying textures to a sur- face of the textile element. ’598 patent at Claim 4. Adidas challenged the claims as obvious in view of: (1) the combination of U.S. Patent Nos. 3,985,003 (Reed) and 5,345,638 (Nishida) (Ground 1) and (2) the combina- tion of Nishida and U.S. Patent Nos. 4,038,840 (Castello) and 6,330,814 (Fujiwara) (Ground 2). 2 The Board held that Adidas had not demonstrated that the challenged claims are unpatentable as obvious under either ground. We re- view the Board’s legal determinations de novo and its fac- tual findings for substantial evidence. In re Van Os, 844 F.3d 1359, 1360 (Fed. Cir. 2017). “Obviousness is a ques- tion of law based on underlying facts.” Arctic Cat Inc. v. Bombardier Recreational Prods.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
963 F.3d 1355, Counsel Stack Legal Research, https://law.counselstack.com/opinion/adidas-ag-v-nike-inc-cafc-2020.